Close-up texture of a white cosmetic cream smeared on a beige surface

Beiersdorf Just Bet Big on Your Skin's Microbiome — Here's What That Means

By Michael C. · Written and reviewed by Michael C.

Skin Microbiome · Published 2026-09-02 · 10 min read · 1806 words · Updated 2026-09-08

Eucerin's new DERMOPURE CLINICAL PROBIOM8 line uses dormant skin-native bacteria to treat acne-prone skin, rather than sterilising it.

Key takeaways

  • Beiersdorf launched Eucerin DERMOPURE CLINICAL PROBIOM8 on 1 September 2026, built around a patented active called TopiC.A.
  • The line uses two viable, dormant strains of skin-native bacteria that activate on skin to support a balanced microbiome.
  • Beiersdorf's microbiome research dates back to the 1990s, with over 120 proprietary studies conducted since 2014.
  • The global acne-prone skin market reached an estimated 4.6 billion euros in 2025, with prevalence highest among 16 to 24-year-olds.
  • South Africa's UV exposure, humidity swings and hard water all add extra stress to the skin barrier and microbiome.

This is a premium briefing. Sign in or see membership plans to read the full article -- free accounts get several full briefings every week.

Source: Beiersdorf (https://www.beiersdorf.com/)

Cover image: Kelsey Curtis — credit